Figure 2.

The effect of Tat-protein (A), Cr (B), GPA (C) or Tat-BCK (D) treatment on uMtCK immunoreactivity in the rat hippocampus. uMtCK immunoreactivity is unaltered after Tat-protein, Cr, GPA or Tat-BCK treatment. Rectangles in panels 1 indicate the regions of panels 2 and 3. Bar = 200 (panel 1) and 25 (panels 2-4) μm.

Kim et al. BMC Neuroscience 2010 11:141   doi:10.1186/1471-2202-11-141
Download authors' original image